Harrisson S et al. Six month interim results of MSDC-0602K in a large phase 2b NASH study demonstrate significant improvement in liver enzymes and glycemic control (NCT02784444). (Abstract PS-111)
Geen hogere mortaliteit COVID-19 bij NSAID-gebruik
jan 2021 | Artrose, Reumatoïde artritis, Virale infecties